AnaBio Technologies Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $1.24M

  • Investors
  • 2

AnaBio Technologies General Information

Description

Provider of encapsulation services intended for the stabilization of food, pharmaceutical, and animal health products. The company develops, validate, commercialize, and license ingredient delivery systems for pharmaceutical companies, enabling pharmaceutical clients to enhance and develop new products with proven, valid claims.

Contact Information

Website
www.anabio.ie
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 11 Herbert Street
  • Dublin D02 RW27
  • Ireland
+353 (01) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AnaBio Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Oct-2020 $1.24M 00.000 Completed Generating Revenue
3. Angel (individual) 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator $5K $865K Completed Startup
1. Capitalization 01-Jan-2011 $860K $860K Completed Startup
To view AnaBio Technologies’s complete valuation and funding history, request access »

AnaBio Technologies Patents

  • 53

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

AnaBio Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202304892-D0 A self-stable packed beverage Pending 31-Mar-2023
GB-202201083-D0 A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix Pending 27-Jan-2022 0000000000
GB-2615103-A A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix Pending 27-Jan-2022 0000000000 0
US-20230080017-A1 Coated microcapsules and methods for the production thereof Pending 19-Feb-2020 0000000000
AU-2021222984-A1 Coated microcapsules and methods for the production thereof Pending 19-Feb-2020 B01J13/22
To view AnaBio Technologies’s complete patent history, request access »

AnaBio Technologies Executive Team (2)

Name Title Board Seat Contact Info
Sinead Bleiel Chief Executive Officer
Jens Bleiel Co-Founder & Board Member
To view AnaBio Technologies’s complete executive team members history, request access »

AnaBio Technologies Board Members (2)

Name Representing Role Since
Dan MacSweeney AnaBio Technologies Chairman 000 0000
Jens Bleiel AnaBio Technologies Co-Founder & Board Member 000 0000
To view AnaBio Technologies’s complete board members history, request access »

AnaBio Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AnaBio Technologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IGNITE Graduate Business Innovation Programme Accelerator/Incubator Minority 000 0000 000000 0
Irrus Investments Angel Group Minority 000 0000 000000 0
To view AnaBio Technologies’s complete investors history, request access »

Ready to get started?

Request a free trial